Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital

BackgroundModel-informed precision dosing (MIPD) can serve as a powerful tool during therapeutic drug monitoring (TDM) to help individualize dosing in populations with large pharmacokinetic variation. Yet, adoption of MIPD in the clinical setting has been limited. Overcoming technologic hurdles that...

Full description

Bibliographic Details
Main Authors: Adam Frymoyer, Hayden T. Schwenk, Yvonne Zorn, Laura Bio, Jeffrey D. Moss, Bhavin Chasmawala, Joshua Faulkenberry, Srijib Goswami, Ron J. Keizer, Shabnam Ghaskari
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-04-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.00551/full
_version_ 1811286033514364928
author Adam Frymoyer
Hayden T. Schwenk
Yvonne Zorn
Laura Bio
Jeffrey D. Moss
Bhavin Chasmawala
Joshua Faulkenberry
Srijib Goswami
Ron J. Keizer
Shabnam Ghaskari
author_facet Adam Frymoyer
Hayden T. Schwenk
Yvonne Zorn
Laura Bio
Jeffrey D. Moss
Bhavin Chasmawala
Joshua Faulkenberry
Srijib Goswami
Ron J. Keizer
Shabnam Ghaskari
author_sort Adam Frymoyer
collection DOAJ
description BackgroundModel-informed precision dosing (MIPD) can serve as a powerful tool during therapeutic drug monitoring (TDM) to help individualize dosing in populations with large pharmacokinetic variation. Yet, adoption of MIPD in the clinical setting has been limited. Overcoming technologic hurdles that allow access to MIPD at the point-of-care and placing it in the hands of clinical specialists focused on medication dosing may encourage adoption.ObjectiveTo describe the hospital implementation and usage of a MIPD clinical decision support (CDS) tool for vancomycin in a pediatric population.MethodsWithin an academic children’s hospital, MIPD for vancomycin was implemented via a commercial cloud-based CDS tool that utilized Bayesian forecasting. Clinical pharmacists were recognized as local champions to facilitate adoption of the tool and operated as end-users. Integration within the electronic health record (EHR) and automatic transmission of patient data to the tool were identified as important requirements. A web-link icon was developed within the EHR which when clicked sends users and needed patient-level clinical data to the CDS platform. Individualized pharmacokinetic predictions and exposure metrics for vancomycin are then presented in the form of a web-based dashboard. Use of the CDS tool as part of TDM was tracked and users were surveyed on their experience.ResultsAfter a successful pilot phase in the neonatal intensive care unit, implementation of MIPD was expanded to the pediatric intensive care unit, followed by availability to the entire hospital. During the first 2+ years since implementation, a total of 853 patient-courses (n = 96 neonates, n = 757 children) and 2,148 TDM levels were evaluated using the CDS tool. For the most recent 6 months, the CDS tool was utilized to support 79% (181/230) of patient-courses in which TDM was performed. Of 26 users surveyed, > 96% agreed or strongly agreed that automatic transmission of patient data to the tool was a feature that helped them complete tasks more efficiently; 81% agreed or strongly agreed that they were satisfied with the CDS tool.ConclusionsIntegration of a vancomycin CDS tool within the EHR, along with leveraging the expertise of clinical pharmacists, allowed for successful adoption of MIPD in clinical care.
first_indexed 2024-04-13T02:53:38Z
format Article
id doaj.art-ef886d4cf4034249bfe305e0b6882dda
institution Directory Open Access Journal
issn 1663-9812
language English
last_indexed 2024-04-13T02:53:38Z
publishDate 2020-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj.art-ef886d4cf4034249bfe305e0b6882dda2022-12-22T03:05:46ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-04-011110.3389/fphar.2020.00551523256Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s HospitalAdam Frymoyer0Hayden T. Schwenk1Yvonne Zorn2Laura Bio3Jeffrey D. Moss4Bhavin Chasmawala5Joshua Faulkenberry6Srijib Goswami7Ron J. Keizer8Shabnam Ghaskari9Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United StatesDepartment of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, United StatesDepartment of Clinical Pharmacy, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesDepartment of Clinical Pharmacy, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesDepartment of Clinical Pharmacy, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesInformation Services, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesInformation Services, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesInsightRx, San Francisco, CA, United StatesInsightRx, San Francisco, CA, United StatesInformation Services, Lucile Packard Children’s Hospital Stanford, Palo Alto, CA, United StatesBackgroundModel-informed precision dosing (MIPD) can serve as a powerful tool during therapeutic drug monitoring (TDM) to help individualize dosing in populations with large pharmacokinetic variation. Yet, adoption of MIPD in the clinical setting has been limited. Overcoming technologic hurdles that allow access to MIPD at the point-of-care and placing it in the hands of clinical specialists focused on medication dosing may encourage adoption.ObjectiveTo describe the hospital implementation and usage of a MIPD clinical decision support (CDS) tool for vancomycin in a pediatric population.MethodsWithin an academic children’s hospital, MIPD for vancomycin was implemented via a commercial cloud-based CDS tool that utilized Bayesian forecasting. Clinical pharmacists were recognized as local champions to facilitate adoption of the tool and operated as end-users. Integration within the electronic health record (EHR) and automatic transmission of patient data to the tool were identified as important requirements. A web-link icon was developed within the EHR which when clicked sends users and needed patient-level clinical data to the CDS platform. Individualized pharmacokinetic predictions and exposure metrics for vancomycin are then presented in the form of a web-based dashboard. Use of the CDS tool as part of TDM was tracked and users were surveyed on their experience.ResultsAfter a successful pilot phase in the neonatal intensive care unit, implementation of MIPD was expanded to the pediatric intensive care unit, followed by availability to the entire hospital. During the first 2+ years since implementation, a total of 853 patient-courses (n = 96 neonates, n = 757 children) and 2,148 TDM levels were evaluated using the CDS tool. For the most recent 6 months, the CDS tool was utilized to support 79% (181/230) of patient-courses in which TDM was performed. Of 26 users surveyed, > 96% agreed or strongly agreed that automatic transmission of patient data to the tool was a feature that helped them complete tasks more efficiently; 81% agreed or strongly agreed that they were satisfied with the CDS tool.ConclusionsIntegration of a vancomycin CDS tool within the EHR, along with leveraging the expertise of clinical pharmacists, allowed for successful adoption of MIPD in clinical care.https://www.frontiersin.org/article/10.3389/fphar.2020.00551/fullvancomycinchildrenpharmacokineticsclinical decision supporttherapeutic drug monitoring
spellingShingle Adam Frymoyer
Hayden T. Schwenk
Yvonne Zorn
Laura Bio
Jeffrey D. Moss
Bhavin Chasmawala
Joshua Faulkenberry
Srijib Goswami
Ron J. Keizer
Shabnam Ghaskari
Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
Frontiers in Pharmacology
vancomycin
children
pharmacokinetics
clinical decision support
therapeutic drug monitoring
title Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
title_full Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
title_fullStr Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
title_full_unstemmed Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
title_short Model-Informed Precision Dosing of Vancomycin in Hospitalized Children: Implementation and Adoption at an Academic Children’s Hospital
title_sort model informed precision dosing of vancomycin in hospitalized children implementation and adoption at an academic children s hospital
topic vancomycin
children
pharmacokinetics
clinical decision support
therapeutic drug monitoring
url https://www.frontiersin.org/article/10.3389/fphar.2020.00551/full
work_keys_str_mv AT adamfrymoyer modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT haydentschwenk modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT yvonnezorn modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT laurabio modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT jeffreydmoss modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT bhavinchasmawala modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT joshuafaulkenberry modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT srijibgoswami modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT ronjkeizer modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital
AT shabnamghaskari modelinformedprecisiondosingofvancomycininhospitalizedchildrenimplementationandadoptionatanacademicchildrenshospital